Try our beta test site
2 studies found for:    24239220 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Interventions: Drug: brentuximab vedotin;   Drug: doxorubicin;   Drug: bleomycin;   Drug: vinblastine;   Drug: dacarbazine
2 Completed A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma
Condition: Disease, Hodgkin
Interventions: Drug: brentuximab vedotin;   Drug: doxorubicin;   Drug: vinblastine;   Drug: dacarbazine;   Drug: bleomycin

Study has passed its completion date and status has not been verified in more than two years.